Clinical Trial Update: NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals [Phase 2]

View source ↗

Summary

Phase 2 NAUTICAL trial assessing natriuretic peptide augmentation for cardiometabolic health in Black individuals; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Diabetes Mellitus

Drugs mentioned

• Natriuretic peptide augmentation

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Diabetes Mellitus, Cardiovascular Diseases | Phase 2 | Status: RECRUITING